A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis

C. Gasperini, A. Paolillo, M. Rovaris, T. A. Yousry, R. Capra, S. Bastianello, M. Filippi

Research output: Contribution to journalArticle

Abstract

We compared the number and volume of enhancing lesions detected in patients with multiple sclerosis (MS) seen on post-contrast T1-weighted scans obtained after the injection of different gadolinium-DTPA (Gd) doses. Enhanced magnetic resonance imaging (MRI) scans were obtained from 16 patients with relapsing remitting or secondary progressive MS on two different occasions separated by an interval of approximately 24 h. On the first occasion, enhanced scans were obtained 15 min after the injection of a double dose of Gd (0.2 mmol/Kg), on the second 15 min after the injection of a triple dose (0.3 mmol/Kg) of Gd. Scans were assessed by consensus in a random order by two observers unaware of the dose of Gd used. We counted the same 30 enhancing lesions on both double dose and triple dose scans from 9 patients. The mean (SD) volumes of enhancing lesions were 1.7 (2.7) mL on double dose and 1.9 (3.4) mL on triple-dose scans. This difference was not statistically significant. This study demonstrated that double dose of Gd has a sensitivity for detecting MS activity similar to that of a triple dose, with the advantage of a significant cost saving. (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)761-763
Number of pages3
JournalMagnetic Resonance Imaging
Volume18
Issue number6
DOIs
Publication statusPublished - 2000

Fingerprint

Pentetic Acid
Gadolinium DTPA
Gadolinium
Magnetic resonance
gadolinium
lesions
Multiple Sclerosis
magnetic resonance
Magnetic Resonance Imaging
Imaging techniques
dosage
sensitivity
Injections
Chronic Progressive Multiple Sclerosis
injection
Costs and Cost Analysis
Costs
costs
intervals

Keywords

  • Blood-brain barrier
  • Gadolinium-DTPA
  • Magnetic resonance imaging
  • Multiple Sclerosis
  • Triple dose

ASJC Scopus subject areas

  • Biophysics
  • Clinical Biochemistry
  • Structural Biology
  • Radiology Nuclear Medicine and imaging
  • Condensed Matter Physics

Cite this

A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis. / Gasperini, C.; Paolillo, A.; Rovaris, M.; Yousry, T. A.; Capra, R.; Bastianello, S.; Filippi, M.

In: Magnetic Resonance Imaging, Vol. 18, No. 6, 2000, p. 761-763.

Research output: Contribution to journalArticle

@article{4de9a14e703745a198edab2b87b709e2,
title = "A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis",
abstract = "We compared the number and volume of enhancing lesions detected in patients with multiple sclerosis (MS) seen on post-contrast T1-weighted scans obtained after the injection of different gadolinium-DTPA (Gd) doses. Enhanced magnetic resonance imaging (MRI) scans were obtained from 16 patients with relapsing remitting or secondary progressive MS on two different occasions separated by an interval of approximately 24 h. On the first occasion, enhanced scans were obtained 15 min after the injection of a double dose of Gd (0.2 mmol/Kg), on the second 15 min after the injection of a triple dose (0.3 mmol/Kg) of Gd. Scans were assessed by consensus in a random order by two observers unaware of the dose of Gd used. We counted the same 30 enhancing lesions on both double dose and triple dose scans from 9 patients. The mean (SD) volumes of enhancing lesions were 1.7 (2.7) mL on double dose and 1.9 (3.4) mL on triple-dose scans. This difference was not statistically significant. This study demonstrated that double dose of Gd has a sensitivity for detecting MS activity similar to that of a triple dose, with the advantage of a significant cost saving. (C) 2000 Elsevier Science Inc.",
keywords = "Blood-brain barrier, Gadolinium-DTPA, Magnetic resonance imaging, Multiple Sclerosis, Triple dose",
author = "C. Gasperini and A. Paolillo and M. Rovaris and Yousry, {T. A.} and R. Capra and S. Bastianello and M. Filippi",
year = "2000",
doi = "10.1016/S0730-725X(00)00156-9",
language = "English",
volume = "18",
pages = "761--763",
journal = "Magnetic Resonance Imaging",
issn = "0730-725X",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis

AU - Gasperini, C.

AU - Paolillo, A.

AU - Rovaris, M.

AU - Yousry, T. A.

AU - Capra, R.

AU - Bastianello, S.

AU - Filippi, M.

PY - 2000

Y1 - 2000

N2 - We compared the number and volume of enhancing lesions detected in patients with multiple sclerosis (MS) seen on post-contrast T1-weighted scans obtained after the injection of different gadolinium-DTPA (Gd) doses. Enhanced magnetic resonance imaging (MRI) scans were obtained from 16 patients with relapsing remitting or secondary progressive MS on two different occasions separated by an interval of approximately 24 h. On the first occasion, enhanced scans were obtained 15 min after the injection of a double dose of Gd (0.2 mmol/Kg), on the second 15 min after the injection of a triple dose (0.3 mmol/Kg) of Gd. Scans were assessed by consensus in a random order by two observers unaware of the dose of Gd used. We counted the same 30 enhancing lesions on both double dose and triple dose scans from 9 patients. The mean (SD) volumes of enhancing lesions were 1.7 (2.7) mL on double dose and 1.9 (3.4) mL on triple-dose scans. This difference was not statistically significant. This study demonstrated that double dose of Gd has a sensitivity for detecting MS activity similar to that of a triple dose, with the advantage of a significant cost saving. (C) 2000 Elsevier Science Inc.

AB - We compared the number and volume of enhancing lesions detected in patients with multiple sclerosis (MS) seen on post-contrast T1-weighted scans obtained after the injection of different gadolinium-DTPA (Gd) doses. Enhanced magnetic resonance imaging (MRI) scans were obtained from 16 patients with relapsing remitting or secondary progressive MS on two different occasions separated by an interval of approximately 24 h. On the first occasion, enhanced scans were obtained 15 min after the injection of a double dose of Gd (0.2 mmol/Kg), on the second 15 min after the injection of a triple dose (0.3 mmol/Kg) of Gd. Scans were assessed by consensus in a random order by two observers unaware of the dose of Gd used. We counted the same 30 enhancing lesions on both double dose and triple dose scans from 9 patients. The mean (SD) volumes of enhancing lesions were 1.7 (2.7) mL on double dose and 1.9 (3.4) mL on triple-dose scans. This difference was not statistically significant. This study demonstrated that double dose of Gd has a sensitivity for detecting MS activity similar to that of a triple dose, with the advantage of a significant cost saving. (C) 2000 Elsevier Science Inc.

KW - Blood-brain barrier

KW - Gadolinium-DTPA

KW - Magnetic resonance imaging

KW - Multiple Sclerosis

KW - Triple dose

UR - http://www.scopus.com/inward/record.url?scp=0033888951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033888951&partnerID=8YFLogxK

U2 - 10.1016/S0730-725X(00)00156-9

DO - 10.1016/S0730-725X(00)00156-9

M3 - Article

C2 - 10930786

AN - SCOPUS:0033888951

VL - 18

SP - 761

EP - 763

JO - Magnetic Resonance Imaging

JF - Magnetic Resonance Imaging

SN - 0730-725X

IS - 6

ER -